ClinicalTrials.Veeva

Menu

Insulin Secretory Capacity in Insulin-independent Pancreas-Kidney Recipients Compared to Controls

U

University Hospital, Gasthuisberg

Status

Unknown

Conditions

Pancreas Transplantation
Kidney Transplantation

Treatments

Other: hyperglycemic clamp test

Study type

Interventional

Funder types

Other

Identifiers

NCT00618761
clamp01
JDRF 4/2005/1327

Details and patient eligibility

About

The purpose of this study is to compare functional beta-cell mass using the hyperglycaemic clamp test in insulin-independent pancreas-kidney recipients with that in non-diabetic kidney recipients and normal controls as well as with the partially previously reported data in beta-cell recipients.

Enrollment

40 estimated patients

Sex

All

Ages

21 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • kidney pancreas recipients
  • kidney recipients
  • healthy volunteers
  • beta-cell recipients
  • immunosuppression with MMF-Tacrolimus
  • 1-4 years after transplantation

Exclusion criteria

  • high doses of steroids
  • insulin dependent

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 4 patient groups

1
Experimental group
Description:
kidney-pancreas recipients
Treatment:
Other: hyperglycemic clamp test
2
Active Comparator group
Description:
kidney recipients
Treatment:
Other: hyperglycemic clamp test
3
Active Comparator group
Description:
healthy controls
Treatment:
Other: hyperglycemic clamp test
4
Active Comparator group
Description:
beta-cell recipients
Treatment:
Other: hyperglycemic clamp test

Trial contacts and locations

1

Loading...

Central trial contact

Chantal Mathieu, M.D., PhD.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems